Is iSpecimen Inc. Common Stock a good investment? iSpecimen Inc. Common Stock (ISPC) is currently trading at 2.01 USD.
Earnings Schedule: iSpecimen Inc. Common Stock is expected to release its next earnings report on Aug. 4, 2026. The market consensus estimate for Forward EPS is -0.79.
No, it does not currently pay a dividend.
iSpecimen Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Aug. 4, 2026. The company currently has a trailing EPS of -316.93.
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. The company's marketplace offers human biospecimens, including biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; solid tissue comprising fresh, fixed, and cryopreserved tissue, as well as formalin-fixed paraffin embedded blocks, slides, and curls; and hematopoietic stem and immune cells, including bone marrow, cord blood, whole blood, or sub-components of these tissues, such as peripheral blood mononuclear cells and other isolated cell types. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Woburn, Massachusetts.
| Split Date | Split Ratio to 1 |
|---|---|
| Sept. 16, 2024 | 0.050000 |
| April 28, 2026 | 0.030000 |
Community Discussion